Thomas Leggett - Chief Financial Officer at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
STOK on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Leggett since 7/7/2023

Holdings reported by Thomas Leggett for Stoke Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 396,200 May 15, 2024 Direct Common Stock

Transactions reported by Thomas Leggett for Stoke Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership